Literature DB >> 16856944

RA domain-mediated interaction of Cdc35 with Ras1 is essential for increasing cellular cAMP level for Candida albicans hyphal development.

Hao-Ming Fang1, Yue Wang.   

Abstract

Many Ras GTPases activate their effectors through binding at a conserved Ras association (RA) domain. An example is the activation of the budding yeast adenylate cyclase Cyr1 by Ras1 and Ras2. Candida albicans Ras1 is speculated to similarly activate Cdc35, the orthologue of Cyr1, for hyphal development. Here, we have investigated whether the RA domain mediates Ras1-Cdc35 interaction and how this interaction regulates cAMP levels and morphogenesis. Yeast two-hybrid assays suggested that Ras1 interacts only with the RA but not any other identifiable domains of Cdc35. The Ras1-RA interaction was further confirmed by in vitro binding assays of purified RA domain and Ras1 and by co-immunoprecipitation of Ras1 and Cdc35 from cell lysates. Substituting Ala for the conserved residue K(338) or L(349) in the RA domain or deleting the RA domain abolished the Ras1-RA or Ras1-Cdc35 interactions. cdc35 mutants with the RA domain deleted or carrying K388A or L349A mutation exhibited rather normal yeast growth but were completely defective in hyphal morphogenesis. Further, the mutants contained nearly wild-type levels of cAMP during yeast growth but were unable to increase it upon hyphal induction. These results suggest an essential role for the RA-mediated Ras1-Cdc35 interaction in raising cellular cAMP levels for hyphal morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856944     DOI: 10.1111/j.1365-2958.2006.05248.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  32 in total

1.  Temporal and spatial control of HGC1 expression results in Hgc1 localization to the apical cells of hyphae in Candida albicans.

Authors:  Allen Wang; Shelley Lane; Zhen Tian; Amir Sharon; Idit Hazan; Haoping Liu
Journal:  Eukaryot Cell       Date:  2006-12-15

Review 2.  Glucose sensing network in Candida albicans: a sweet spot for fungal morphogenesis.

Authors:  Jeffrey Sabina; Victoria Brown
Journal:  Eukaryot Cell       Date:  2009-07-17

Review 3.  Growth of Candida albicans hyphae.

Authors:  Peter E Sudbery
Journal:  Nat Rev Microbiol       Date:  2011-08-16       Impact factor: 60.633

4.  Dimorphic Mechanism on cAMP Mediated Signal Pathway in Mucor circinelloides.

Authors:  Maki Moriwaki-Takano; Ryo Iwakura; Kazuhiro Hoshino
Journal:  Appl Biochem Biotechnol       Date:  2020-05-18       Impact factor: 2.926

5.  cAMP-independent signal pathways stimulate hyphal morphogenesis in Candida albicans.

Authors:  Salvatore M Parrino; Haoyu Si; Shamoon Naseem; Kevin Groudan; Justin Gardin; James B Konopka
Journal:  Mol Microbiol       Date:  2016-12-19       Impact factor: 3.501

Review 6.  Modulation of morphogenesis in Candida albicans by various small molecules.

Authors:  Julie Shareck; Pierre Belhumeur
Journal:  Eukaryot Cell       Date:  2011-06-03

7.  CO(2) acts as a signalling molecule in populations of the fungal pathogen Candida albicans.

Authors:  Rebecca A Hall; Luisa De Sordi; Donna M Maccallum; Hüsnü Topal; Rebecca Eaton; James W Bloor; Gary K Robinson; Lonny R Levin; Jochen Buck; Yue Wang; Neil A R Gow; Clemens Steegborn; Fritz A Mühlschlegel
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

8.  Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans.

Authors:  Allia K Lindsay; Aurélie Deveau; Amy E Piispanen; Deborah A Hogan
Journal:  Eukaryot Cell       Date:  2012-08-10

9.  Bacterial peptidoglycan-derived molecules activate Candida albicans hyphal growth.

Authors:  Yue Wang; Xiao-Li Xu
Journal:  Commun Integr Biol       Date:  2008

10.  Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis.

Authors:  Amber Davis-Hanna; Amy E Piispanen; Lubomira I Stateva; Deborah A Hogan
Journal:  Mol Microbiol       Date:  2008-01       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.